@FierceMedDev: Med tech VC investing remains sluggish, biotech surges. Report | Follow @FierceMedDev
@MarkHFierce: Google is backing Dx company SynapDx in its new $15.4M funding round. Release (PDF) | Follow @MarkHFierce
@DamianFierce: Mela's melanoma-finding device was hailed as a major advance on FDA approval, but docs remain wary. Story | Follow @DamianFierce
> Omar Ishrak's strategies for revamping Medtronic ($MDT) during his first two years as CEO are drawing attention and raves. Story
> Gamma Medica nailed down a $16 million Series A funding round toward expanded commercialization of its molecular imaging system for dense breast tissue and a companion biopsy module. Item
> Terumo has kicked off a U.S. trial of its FRED flow diversion system to treat intracranial aneurysms. News
> The FDA has assigned its most serious warning to Bryan Medical's recall of a tracheostomy tube, warning that a packaging error could put patients in danger. More
> Australia's Saluda Medical nailed down $4.6 million in new funding toward development of an electronic stimulation device to treat chronic pain. Story
> Stryker ($SYK) scored high in a recent Gallup poll that measured employee engagement. Story
> Israel's ETView Medical has inked an exclusive distribution deal with MEDITRADE that will give its ViviSight ventilation tube/airway imaging devices access to markets in Slovakia, the Czech Republic and Poland. Item
> Startup Curvo Labs in Indiana scored some initial funding for a product that would connect hospitals and medical device companies via big data. Story
> HistoGenetics will use Illumina's ($ILMN) MiSeq sequencing system in its CLIA laboratory to help test for HLA gene variations, which are connected to many autoimmune and infectious diseases, plus some cancers. Item
Biotech News
@FierceBiotech: Popular this weekend - Report: Pfizer backs off Onyx bid as price gets too rich. Article | Follow @FierceBiotech
@JohnCFierce: Report: Big Pharma mounts secret attack against data transparency rule - (some companies will never learn). Report | Follow @JohnCFierce
@RyanMFierce: Roche is still undecided about new chair. Art Levinson dismissed as "too radical." Reuters' article | Follow @RyanMFierce
@EmilyMFierce: New 3-D model of diabetes target could shape drug design. More | Follow @EmilyMFierce
> Does Roche need a biotech brain in the chairman's office? Story
> Isis Pharma fuels fervor for cardio drug with more midstage data. Report
> Biotech vets pick up $10M B round for startup Alcresta. News
Pharma News
@FiercePharma: Chinese police pick up AstraZeneca sales rep for questioning. AZN says no reason to think it's part of bribery probe. Report | Follow @FiercePharma
@CarlyHFierce: Reuters says Roche may have to turn to an outsider for its chairman hunt. News | Follow @CarlyHFierce
> Chile's CFR wins shareholder OK for Adcock buyout financing. Story
> GlaxoSmithKline exec admits "breaches," promises price cuts in China. Article
CRO News
> ResearchDx expands to meet contract diagnostics demand. Report
> CROs large and small get serious about eClinical. More
> Aesica teams with QRxPharma for abuse-deterrence tech. Item
> CRO Solutions spins niche services into new biz. Story
> AstraZeneca picks Tufts for outsourcing-heavy neuro program. Article
> WuXi, PRA snag ex-Theorem CEO to head China JV. News
Biotech IT News
> J&J searching for European digital health entrepreneurs. Item
> Chinese CRO buys software to bridge gap to global clients. More
> Bioinformatics buy bolsters Life Technologies' diagnostics pact with Merck Serono. Story
> With pharma clientele, Big Data-mapping startup Ayasdi lands $30.6M financing. Article